{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:02Z","timestamp":1786119182000,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/iae.0b013e318158e9f7","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T18:30:03Z","timestamp":1236105003000},"page":"1142-1147","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic and Therapeutic Challenges"],"prefix":"10.1097","volume":"27","author":[{"given":"Jennifer","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hunyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Karacorlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease.","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R2-27-20210130","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0161-6420(01)00758-8","article-title":"Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease.","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"key":"R3-27-20210130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease.","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"key":"R4-27-20210130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.33.2.120","article-title":"A genetic register for von Hippel-Lindau disease.","volume":"33","author":"Maddoc","year":"1996","journal-title":"J Med Genet"},{"key":"R5-27-20210130","first-page":"276","article-title":"Retinal angiomatosis: the ocular manifestations of von Hippel-Lindau disease.","volume":"21","author":"Ridley","year":"1986","journal-title":"Can J Ophthalmol"},{"key":"R6-27-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.117.3.371","article-title":"Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.","volume":"117","author":"Webster","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R7-27-20210130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archopht.1968.00980050634010","article-title":"Incipient lesions of von Hippel-Lindau disease.","volume":"80","author":"Jesberg","year":"1968","journal-title":"Arch Ophthalmol"},{"key":"R8-27-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9394(86)90592-1","article-title":"Rhegmatogenous retinal detachment in angiomatosis retinae.","volume":"101","author":"Nicholson","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"R9-27-20210130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-9394(89)90434-0","article-title":"Peripheral retinal angioma-like lesion and macular pucker.","volume":"108","author":"Laatikainen Limmonen","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"R10-27-20210130","first-page":"615","article-title":"Retina.","author":"Hinz","year":"2006"},{"key":"R11-27-20210130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00006982-200204000-00019","article-title":"Treatment of angiomatous lesions of the retina with photodynamic therapy.","volume":"22","author":"Rodriguez-Coleman","year":"2002","journal-title":"Retina"},{"key":"R12-27-20210130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archopht.123.3.328","article-title":"Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy.","volume":"123","author":"Aaberg","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R13-27-20210130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/1542-8877-20000701-14","article-title":"Transpupillary thermotherapy for retinal capillary hemangioma in von Hippel-Lindau disease.","volume":"31","author":"Parmar","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"R14-27-20210130","first-page":"65","article-title":"Treatment of retinal detachment in von Hippel-Lindau disease.","volume":"218","author":"Jansen","year":"1986","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"R15-27-20210130","first-page":"550","article-title":"Management of macular puckers associated with retinal angiomas.","volume":"21","author":"Schwartz","year":"1990","journal-title":"Ophthalmic Surg"},{"key":"R16-27-20210130","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0161-6420(98)98017-4","article-title":"Ruthenium-106 brachytherapy for peripheral retinal capillary haemangioma.","volume":"105","author":"Kreusel","year":"1998","journal-title":"Ophthalmology"},{"key":"R17-27-20210130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ophtha.2003.04.003","article-title":"Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomical outcomes.","volume":"111","author":"Raja","year":"2004","journal-title":"Ophthalmology"},{"key":"R18-27-20210130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene.","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"R19-27-20210130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"R20-27-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease.","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"R21-27-20210130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1008213320642","article-title":"Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.","volume":"8","author":"Los","year":"1997","journal-title":"Ann Oncol"},{"key":"R22-27-20210130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","article-title":"VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.","volume":"117","author":"Chan","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R23-27-20210130","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1634\/theoncologist.5-suppl_1-32","article-title":"von Hippel-Lindau syndrome: target for antivascular endothelial growth factor (VEGF) receptor therapy.","volume":"5","author":"Harris","year":"2000","journal-title":"Oncologist"},{"key":"R24-27-20210130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","article-title":"Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416.","volume":"109","author":"Aiello","year":"2002","journal-title":"Ophthalmology"},{"key":"R25-27-20210130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R26-27-20210130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.291.8.943","article-title":"Antiangiogenic therapy for von Hippel-Lindau disease.","volume":"291","author":"Madhusudan","year":"2004","journal-title":"JAMA"},{"key":"R27-27-20210130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/IAE.0b013e318030a290","article-title":"Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.","volume":"27","author":"Dahr","year":"2007","journal-title":"Retina"},{"key":"R28-27-20210130","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/diab.46.9.1473","article-title":"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.","volume":"46","author":"Aiello","year":"1997","journal-title":"Diabetes"},{"key":"R29-27-20210130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells.","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R30-27-20210130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/ajrcmb.16.4.9115750","article-title":"Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is down regulated by corticosteroids.","volume":"16","author":"Nauck","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R31-27-20210130","first-page":"495","article-title":"Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations.","volume":"102","author":"Chew","year":"2005","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-200710000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:46:09Z","timestamp":1786038369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200710000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318158e9f7","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}